Does the evidence matter in medicine? The retinoblastoma paradigm

International Journal of Cancer

Volumn 121, Issue 11, 2007, Pages 2501-2505

  Mastrangelo, Domenico ^a   De Francesco, Sonia ^a   Di Leonardo, Aldo ^b   Lentini, Laura ^b   Hadjistilianou, Theodora ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Department of Cell and Developmental Biology AMonroy ^*  (Italy)

Author keywords

Aneuploidy; Chromosome instability; Epigenetic; Microsatellite instability; Retinoblastoma; Two hit theory

Indexed keywords

AGE DISTRIBUTION; ANEUPLOIDY; ARTICLE; CANCER INCIDENCE; CHILDHOOD CANCER; CHROMOSOMAL INSTABILITY; EPIGENETICS; GENE MUTATION; HUMAN; INTERNET; LIVE BIRTH; PATHOGENESIS; PRIORITY JOURNAL; RETINOBLASTOMA;

AGE DISTRIBUTION; ANEUPLOIDY; CHROMOSOMAL INSTABILITY; EPIGENESIS, GENETIC; EVIDENCE-BASED MEDICINE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; MICROSATELLITE INSTABILITY; MUTATION; RETINOBLASTOMA;

EID: 35648976977     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22944     Document Type: Article

References (49)

1. Karcioglu ZA, Hadjistilianou T. Ocular tumors. In: Karcioglu ZA, ed. Orbital tumors - diagnosis and treatment. New York: Springer, 2004. 257-65.
2. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;4:820-3.
3. T'Ang A, Wu KJ, Hashimoto T, Liu WY, Takahashi R, Shi XH, Mihara K, Zhang FH, Chen YY, Du C. Genomic organization of the human retinoblastoma gene. Oncogene 1989;4:401-7.
4. http://www.retinoblastoma.com/
5. http://www.cancer.gov/cancertopics/types/retinoblastoma/
6. http://www.geneclinics.org/profiles/retinoblastoma/details.html
7. Blanquet V, Turleau C, Gross-Morand S, Sénamaud-Beaufort C, Doz F, Besmond C. Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma. Hum Mol Genet 1995;4:383-88.
8. Richter S, Vandezande K, Chen N, Zhang K, Sutherland J, Anderson J, Han L, Panton R, Branco P, Gallie B. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet 2003;72:253-69.
9. http://www.retinoblastomasolutions.org/testsent.html
10. Nichols KE, Houseknecht MD, Godmilow L, Bunin G, Shields C, Meadows A, Ganguly A. Sensitive multistep clinical molecular screening of 180 unrelated individuals with retinoblastoma detects 36 novel mutations in the RB1 gene. Hum Mutat 2005;6:566-74.
11. http://www.cancerindex.org/geneweb/RB1.htm#t51
12. Bellan C, De Falco G, Lazzi S, Micheli P, Vicidomini S, Schurfeld K, Amato T, Palumbo A, Bagella L, Sabattini E, Bartolommei S, Hummel M et al. Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation. Invest Ophthalmol Vis Sci 2002;43:3602-8.
13. Harada K, Toyooka S, Maitra A, Maruyama R, Toyooka KO, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Minna JD, Gazdar AF. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Oncogene 2002;21:4345-9.
14. Harada K, Toyooka S, Shivapurkar N, Maitra A, Reddy JL, Matta H, Miyajima K, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Chaudhary PM et al. Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. Cancer Res 2002;62:5897-901.
15. Rathi A, Virmani AK, Harada K, Timmons CF, Miyajima K, Hay RJ, Mastrangelo D, Maitra A, Tomlinson GE, Gazdar AF. Aberrant methylation of the HIC1 promoter is a frequent event in specific pediatric neoplasms. Clin Cancer Res 2003;9(10 Part 1):3674-8
16. Shigematsu H, Suzuki M, Takahashi T, Miyajima K, Toyooka S, Shivapurkar N, Tomlinson GE, Mastrangelo D, Pass HI, Brambilla E, Sathyanarayana UG, Czerniak B et al. Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies. Int J Cancer 2005;113:600-4.
17. Duesberg P. Chromosomal chaos and cancer. Sci Am 2007;296:53-59.
18. Duesberg P, Li R, Fabarius A, Hehlmann R. The chromosomal basis of cancer. Cell Oncol 2005;27:293-318, Review.
19. Duesberg P, Li R, Fabarius A, Hehlmann R. Aneuploidy and cancer: from correlation to causation. Contrib Microbiol 2006;13:16-44, Review.
20. Charames GS, Bapat B. Genomic instability and cancer. Curr Mol Med 2003;3:589-96.
21. Raptis S, Bapat B. Genomic instability in human tumours. EXS 2006;(96):303-20.
22. Hede K. Which came first? Studies clarify role of aneuploidy in cancer. J Natl Cancer Inst 2005;97:87-9.
23. Lentini L, Pipitone L, Di Leonardo A. Functional inactivation of pRB results in aneuploid mammalian cells after release from a mitotic block. Neoplasia 2002;4:380-7.
24. Hernando E, Nahle Z, Juan G, Diaz-Rodriguez E, Alaminos M, Hemann M, Michel L, Mittal V, Gerald W, Benezra R, Lowe SW, Cordon-Cardo C. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 2004;430:797-802.
25. Doxsey S, Zimmerman W, Mikule K. Centrosome control of the cell cycle. Trends Cell Biol 2005;6:303-11, Review
26. Iovino F, Lentini L, Amato A, Di Leonardo A. RB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts. Mol Cancer 2006;5:38.
27. Duensing S, Duensing A, Lee DC, Edwards KM, Piboonniyom SO, Manuel E, Skaltsounis L, Meijer L, Munger K. Cyclin-dependent kinase inhibitor indirubin-3′-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomalies. Oncogene 2004;23:8206-15.
28. Kadaja M, Sumerina A, Verst T, Ojarand M, Ustav E, Ustav M. Genomic instability of the host cell induced by the human papillomavirus replication machinery. EMBO J 2007;26:2180-91.
29. Orjuela M, Castaneda VP, Ridaura C, Lecona E, Leal C, Abramson DH, Orlow I, Gerald W, Cordon-Cardo C. Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor development. Clin Cancer Res 2000;6:4010-16.
30. Frank SA. Age-specific incidence of inherited versus sporadic cancers: a test of the multistage theory of carcinogenesis. Proc Natl Acad Sci 2005;102:1071-75.
31. Knudson AG. A personal sixty-year tour of genetics and medicine. Ann Rev Gen Hum Genet 2005;6:1-14. http://www.cancerindex.org/geneweb/RB1.htm#t51
32. Mastrangelo D, Acquaviva A, Di Pisa F, Hadjistilianou T, Frezzotti R. Italian register for retinoblastoma. Pros and cons of a retrospective statistical study. Ophthalmic Paediatr Genet 1991;12:73-8.
33. http://www.ruf.rice.edu/~lane/stat_sim/descriptive/index.html
34. Pendergrass TW, Davis S. Incidence of retinoblastoma in the United States. Arch Ophthalmol 1980;98:1204-10.
35. Tamboli A, Podgor MJ, Horn JW. The incidence of retinoblastoma in the United States: 1974 through 1985. Arch Ophthalmol 1990;108:128-32.
36. Sanders BM, Draper GJ, Kingston JE. Retinoblastoma in Great Britain 1969-80: incidence, treatment, and survival. Br J Ophthalmol 1988;72:576-83.
37. Mastrangelo D, Acquaviva A, Di Pisa F, Hadjistilianou T, Frezzotti R. Italian register for retinoblastoma. Pros and cons of a retrospective statistical study. Ophthalmic Paediatr Genet 1991;12:73-8.
38. Abramson DH, Ellsworth RM, Grumbach N, Kitschin FD. Retinoblastoma: survival, age at detection and comparison 1914-58, 1958-83. J Paediatr Ophthalmol Strabismus 1985;22:246-50.
39. Gunalp I, Gunduz K, Arslan Y. Retinoblastoma in Turkey: diagnosis and clinical characteristics. Ophthalm Genet 1996;17:21-27.
40. Matsunaga E, Minoda K, Sasaki MS. Parental age and seasonal variation in the births of children with sporadic retinoblastoma: a mutation-epidemiologic study. Hum Genet 1990;84:155-58.
41. http://ghr.nlm.nih.gov/condition=retinoblastoma
42. http://www.medterms.com/script/main/art.asp?articlekey=9723
43. van der Groep P, Bouter A, van der Zanden R, Siccama I, Menko FH, Gille JJP, van Kalken C, van der Wall E, Verheijen RHM, van Diest PJ. Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data. J Clin Pathol 2006;59:611-17.
44. Stiller C, Parkin D. Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull 1996;52:682-703.
45. Stiller CA. Epidemiology and genetics of childhood cancer. Oncogene 2004;23:6429-44.
46. Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol 2004;138:329-37.
47. Shields CL, Meadows AT, Leahey AM, Shields JA. Continuing challenges in the management of retinoblastoma with chemotherapy. Retina 2004;24:849-62.
48. Mastrangelo D, Lore C. "Back stage" view on "hereditary" cancer in ophthalmology: the retinoblastoma paradigm. Med Sci Monit 2005;11:LE3-4.
49. http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijovs/vol1n2/ gene.xml